Akut miyokard infarktüsü seyrinde periferik kök hücre ve beyaz küre sayımının ekokardiyografik ve klinik parametreler ile korelasyonu

Yıl 2022, , 149 - 157, 01.01.2022

Özgür Taşköylü , Taner Değirmenci , Halil Tanrıverdi

https://doi.org/10.31362/patd.1015020

Öz

Amaç: İnflamasyon aterosklerozun ve klinik komplikasyonlarının önemli bir komponentidir. Bu sebeple; akut miyokard infarktüsü seyrinde inflamatuvar belirteçlerin kullanımı giderek önem kazanmaktadır. Lökositler bu inflamatuvar süreçte belirgin rol oynamaktadır. Son dönemde akut miyokard infarktüsü seyrinde kök hücre infüzyonu tedavileri yoğun bir şekilde incelenmiştir. Bu çalışmada farklı olarak; spontan periferik kök hücre mobilizasyonun ve beyaz küre altgrup sayımlarının; akut miyokard infarktüsü sonrası sol ventrikül fonksiyonlarındaki düzelme ile ilişkisinin ekokardiyografik olarak incelenmesi amaçlanmıştır.
Gereç ve yöntem: Çalışmamıza akut miyokard infarktüsü nedeniyle kliniğimize başvuran 28 hasta dahil edilmiştir. Yirmi hastaya primer PKG uygulanmış olup 8 hastaya t-PA infüzyonu yapılmıştır.
Bulgular: Lenfosit değerlerinin AMI seyrinde düşüş gösterdiği ve 30. gün kontrollerinde de düşük olarak saptandığı görülmüştür. Bazal lenfosit sayımları CK-MB ile güçlü ve troponin-I ile orta düzeyde negatif korele olarak saptanmıştır (r = -0,668, p=0,001 ve r = -0,465, p=0,01). Lenfosit düzeyleri ile SVEF arasında pozitif korelasyon saptanırken DHSİ ile negatif korelasyon saptanmıştır (r= 0,403, p=0,03 ve r=-0,598, p=0,01). CD34 (+) kök hücre düzeyleri ile SVEF deki değişim arasında pozitif korelasyon saptanmıştır ( r=0,585, p=0,005) CD34 (+) kök hücre düzeyleri ile DHSİ deki değişim arasında orta düzeyde negatif korelasyon saptanmıştır (r=-0,562, p=0,008). AMİ seyri sırasında; periferik lenfosit düzeylerinin SVEF, DHSİ değerlerindeki değişimler ve kardiyak enzim ile korele olduğu saptanmıştır. Periferik CD34 (+) kök hücre düzeyleri ise SVEF, DHSİ gibi ekokardiyografik parametreler ile korele olarak saptanmıştır.
Sonuç: Verilerimiz; lenfositlerin AMI seyrinde aktif rollerinin olduğunu ve lenfopeni düzeylerinin biyomarker olarak kullanılabileceğini düşündürmektedir.

Anahtar Kelimeler

Akut miyokard infarktüsü, lenfosit, kök hücre

Kaynakça

• 1. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340: 115-26. doi: 10.1056/NEJM199901143400207 2. Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997;79: 17-23. doi: 10.1016/s0002-9149(97)00381-0. 3. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69: 377-381. doi: 10.1136/hrt.69.5.377.
• 4. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50. doi: 10.1161/01.cir.91.11.2844.
• 5. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating Levels of Proinflammatory Cytokines and Neutrophil-Platelet Aggregates in Patients With Coronary Artery Disease. Am J Cardiol 2005;95: 452-456. doi: 10.1016/j.amjcard.2004.10.009.
• 6. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-merican and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001;154: 758-764. doi: 10.1093/aje/154.8.758.
• 7. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54: 316-322. doi: 10.1016/s0895-4356(00)00296-1.
• 8. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96: 1102-1108. doi: 10.1161/01.cir.96.4.1102.
• 9. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982;116: 496-509. doi: 10.1093/oxfordjournals.aje.a113434.
• 10. Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137: 49-53. doi: 10.1093/oxfordjournals.aje.a116601.
• 11. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5: 434-438. doi: 10.1038/7434.
• 12. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005;26:1196-1204. doi: 10.1093/eurheartj/ehi164.
• 13. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21: 1502-1513. doi: 10.1053/euhj.2000.2305.
• 14. Van de WF, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24: 28-66. doi: 10.1016/s0195-668x(02)00618-8.
• 15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, FeigenbaumH, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2: 358-367. doi: 10.1016/s0894-7317(89)80014-8.
• 16. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990;119: 1262-1267. doi: 10.1016/s0002-8703(05)80173-5.
• 17. Shinozaki K, Tamura A, Watanabe T, Nakaishi T, Nagase K, Yufu F, et al. Significance of neutrophil counts after reperfusion therapy inpatients with a first anterior wall acute myocardial infarction. Circ J 2005;69: 526-529. doi: 10.1253/circj.69.526.
• 18. Takahashi T, Hiasa Y, Ohara Y, Miyazaki S, Ogura R, Suzuki N, et al. Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction. Circ J 2008;72: 867-872. doi: 10.1253/circj.72.867.
• 19. Mariani M, Fetiveau R, Rossetti E, Poli A, Poletti F, Vandoni P, et.al. Significance of total and differential leucocytes count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J 2006;27: 2511-2515. doi: 10.1093/eurheartj/ehl191.
• 20. Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, Mainar L, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008;101:747-752. doi: 10.1016/j.amjcard.2007.11.004.
• 21. Wong CK, French JK, Gao W, White HD. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. Am Heart J 2003;145: 95-102. doi: 10.1067/mhj.2003.64.
• 22.Thomson SP, McMahon LJ, Nugent CA.Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol. 1980;17:506-514. doi: 10.1016/0090-1229(80)90146-4.
• 23. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CGA, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998;97:19-22. doi: 10.1161/01.cir.97.1.19.
• 24. Widmer A, Linka AZ, Attenhofer Jost CH, Buergi B, Brunner-La Rocca HP, et al. Mechanical complications after myocardial infarction reliably predicted using Creactive protein levels and lymphocytopenia. Cardiology 2003;99:25-31. doi: 10.1159/000068448.
• 25. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150. doi: 10.1056/NEJMra021333.
• 26. A Abbate, R Bussani, G Liuzzo, G. G. L. Biondi-Zoccai, E Barresi, P Mellone, et al. Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. Heart 2008;94;737-742. doi: 10.1136/hrt.2007.115329.
• 27. Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002;40:1579-1588. doi: 10.1016/s0735-1097(02)02376-8.
• 28. Pasqui AL, Di Renzo M, Bova G, Puccetti L, Bruni F, Saletti M, et al. Lymphocyte apoptosis in non-ST segment elevation acute myocardial infarction. Ann Ital Med Int 2003;18: 154-161.
• 29. Bossowska A, Bossowski A, Galar B. Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome. Kardiol Pol 2007;65(8):883-9.
• 30. Ducloux D, Challier B, Saas P, Tiberghien P, Chalopin JM. CD4 cell lymphopenia andatherosclerosis in renal transplant recipients. J Am Soc Nephrol 2003;14: 767-772. doi: 10.1097/01.asn.0000048718.43419.44.
• 31. Blum A, Sclarovsky S, Rehavia E, Shohat B. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 1994;27: 1226–1230. doi: 10.1016/0002-8703(94)90040-x.
• 32. Al-Ahmad RS, Mahafzah AM, Al-Mousa EN .Immunological changes in acute myocardial infarction. Saudi Med J 2004;25(7):923-8.
• 33. Goronzy JJ, Weyand CM. Immunosuppression in atherosclerosis. Circulation 2006;114: 1901-1904. doi: 10.1161/CIRCULATIONAHA.106.656751.
• 34. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89: 1-7.
• 35. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible forpostnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228. doi: 10.1161/01.res.85.3.221.
• 36. Wojakowski W, Tendera M, Zebzda A, Michalowska A, Majka M, Kucia M, et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 2006;27:283-289. doi: 10.1093/eurheartj/ehi628.